2 days ago
Ever since I started managing my own household, I'd dreamed of having a membership to Costco.
Friends with memberships told me about the beautiful fruits and vegetables, amazing deals on alcohol and bargains on peanut ****** er and coffee. I ogled Pinterest meal plans where people would extol the value of Costco.
Costco sounded like a foodie paradise. But since it was just my husband and me, I couldn't justify the annual expense of the $65 membership, not knowing whether we'd be able maximize it. Would the membership be worth it, even though we weren't shopping for a big family?
Then, my husband and I adopted a dog, and his foster mom recommended purchasing Costco dog food because of its quality and value. That's when we decided to take the plunge and buy a membership.
Since then, I've enjoyed shopping at Costco as much as I thought I would, although there's been a bit of a learning curve.
#costco #membership #value #husband
Friends with memberships told me about the beautiful fruits and vegetables, amazing deals on alcohol and bargains on peanut ****** er and coffee. I ogled Pinterest meal plans where people would extol the value of Costco.
Costco sounded like a foodie paradise. But since it was just my husband and me, I couldn't justify the annual expense of the $65 membership, not knowing whether we'd be able maximize it. Would the membership be worth it, even though we weren't shopping for a big family?
Then, my husband and I adopted a dog, and his foster mom recommended purchasing Costco dog food because of its quality and value. That's when we decided to take the plunge and buy a membership.
Since then, I've enjoyed shopping at Costco as much as I thought I would, although there's been a bit of a learning curve.
#costco #membership #value #husband
2 days ago
Retirees may see property taxes climb even after the mortgage is gone, but the federal tax treatment is not always intuitive. Whether those payments actually reduce a tax bill can depend on how they fit with the rest of a return — and on several 2026 deduction rules.
Here's how to think through which way to deduct these taxes.
Find Out: Worried about market swings? See why investors are moving to gold and silver IRAs
Grow Rich: FREE 2026 Investor Guide + Up to $25,000 in Silver with Qualifying Purchases
Property taxes on a personal residence are an itemized deduction, not an amount taxpayers can simply add to the standard deduction, according to Jim Swiech, a certified public accountant (CPA) and founder at Go Beyond Tax. Retirees should compare their complete itemized totals with their standard deductions, then take whichever is larger.
#retirees #silver #worried
Here's how to think through which way to deduct these taxes.
Find Out: Worried about market swings? See why investors are moving to gold and silver IRAs
Grow Rich: FREE 2026 Investor Guide + Up to $25,000 in Silver with Qualifying Purchases
Property taxes on a personal residence are an itemized deduction, not an amount taxpayers can simply add to the standard deduction, according to Jim Swiech, a certified public accountant (CPA) and founder at Go Beyond Tax. Retirees should compare their complete itemized totals with their standard deductions, then take whichever is larger.
#retirees #silver #worried
29 days ago
Emma Stone wasted little time taking Louis Vuitton's spring 2027 collection off the runway. On Wednesday night, just one day after the collection debuted in Paris, the actress wore one of its newest designs to the premiere of "The Debut" at Lincoln Center's Alice Tully Hall during the 2026 New York Film Festival.
Emma Stone
The two-time Oscar-winning actress turned to the French luxury fashion house's spring 2027 ready-to-wear collection, which debuted at the Louvre's Cour Carrée on Tuesday. Stone opted for an airy style that was trending among celebrities during Paris Fashion Week, wearing a customized version of the fifth look from the collection.
More from WWD
Katseye's Paris Fashion Week Bag Rotation Included Ultra-Rare Louis Vuitton x Singer Styles and Loewe's Trendy Whisker
#Paris #emma #time #spring
Emma Stone
The two-time Oscar-winning actress turned to the French luxury fashion house's spring 2027 ready-to-wear collection, which debuted at the Louvre's Cour Carrée on Tuesday. Stone opted for an airy style that was trending among celebrities during Paris Fashion Week, wearing a customized version of the fifth look from the collection.
More from WWD
Katseye's Paris Fashion Week Bag Rotation Included Ultra-Rare Louis Vuitton x Singer Styles and Loewe's Trendy Whisker
#Paris #emma #time #spring
1 month ago
Mena Massoud
Playing the leading role in a major Hollywood blockbuster that earned a billion dollars is the dream of many in the entertainment world. To do so alongside one of the biggest movie stars of all time, Will Smith, was certainly a dream come true for Mena Massoud. I sat down with him to unpack a hidden secret to career success that is not often discussed: the art of defiant surrender.
For many who lead companies or compete at a high level, it can feel like every moment must be maximized and every outcome manipulated. The performance literature points us somewhere else, to a flow state in which the brain is not preoccupied with holding tightly to every future outcome.
It may seem counterintuitive, but this liberates the brain to be in a place to actually access its best abilities.
Mena Massoud
#MENA #brain
Playing the leading role in a major Hollywood blockbuster that earned a billion dollars is the dream of many in the entertainment world. To do so alongside one of the biggest movie stars of all time, Will Smith, was certainly a dream come true for Mena Massoud. I sat down with him to unpack a hidden secret to career success that is not often discussed: the art of defiant surrender.
For many who lead companies or compete at a high level, it can feel like every moment must be maximized and every outcome manipulated. The performance literature points us somewhere else, to a flow state in which the brain is not preoccupied with holding tightly to every future outcome.
It may seem counterintuitive, but this liberates the brain to be in a place to actually access its best abilities.
Mena Massoud
#MENA #brain
1 month ago
Christy Carlson Romano knows how to play a role, but finding herself has proven to be her greatest performance.
The Emmy-nominated actress and Disney Channel alum looks back on her turbulent upbringing in the spotlight in her debut memoir "Once Upon a Trainwreck: The Fall and Rise of a Child Star" (out now).
Romano, alongside fellow Disney darlings Shia LaBeouf, Hilary Duff and Raven-Symoné, epitomized teen stardom in the early 2000s, appearing in beloved TV shows and movies such as "Even Stevens," "Cadet Kelly" and "Kim Possible."
Despite her success, Romano often felt adrift in young Hollywood, intimidated by the upper echelons of prime-time dramas and glossy magazine covers.
"Looking back, I was really just trying to fit into whatever opportunity was thrown my way, rather than kind of create my own identity so that opportunities would find me in a different light," Romano tells USA TODAY. "I didn't have a stylist or a publicist, and I didn't really invest in myself the way that maybe I should have, to get to know exactly who I wanted to be, even if [that] changed over the years."
#really
The Emmy-nominated actress and Disney Channel alum looks back on her turbulent upbringing in the spotlight in her debut memoir "Once Upon a Trainwreck: The Fall and Rise of a Child Star" (out now).
Romano, alongside fellow Disney darlings Shia LaBeouf, Hilary Duff and Raven-Symoné, epitomized teen stardom in the early 2000s, appearing in beloved TV shows and movies such as "Even Stevens," "Cadet Kelly" and "Kim Possible."
Despite her success, Romano often felt adrift in young Hollywood, intimidated by the upper echelons of prime-time dramas and glossy magazine covers.
"Looking back, I was really just trying to fit into whatever opportunity was thrown my way, rather than kind of create my own identity so that opportunities would find me in a different light," Romano tells USA TODAY. "I didn't have a stylist or a publicist, and I didn't really invest in myself the way that maybe I should have, to get to know exactly who I wanted to be, even if [that] changed over the years."
#really
1 month ago
A woman who accused seven members of a fraternity at Cornell University in 2024 of rape reportedly told the school's investigators that she "felt like bait" on the night of the alleged ***** ault.
"I felt like lions around me," she said during a 2025 hearing, according to ABC News. "It just was a totally debilitating place to be in."
The comments were included in a 99-page report prepared by the university as part of its ***** le IX investigation, per ABC.
The report also included comments from a fraternity member who Cornell's investigation concluded did not engage in the ***** ault but was found responsible for "attempted ***** ual exploitation."
"I was sorry that maybe if it wasn't consensual and she was victimized, I was sorry for not stopping it," the fraternity members said, according to ABC.
#according
"I felt like lions around me," she said during a 2025 hearing, according to ABC News. "It just was a totally debilitating place to be in."
The comments were included in a 99-page report prepared by the university as part of its ***** le IX investigation, per ABC.
The report also included comments from a fraternity member who Cornell's investigation concluded did not engage in the ***** ault but was found responsible for "attempted ***** ual exploitation."
"I was sorry that maybe if it wasn't consensual and she was victimized, I was sorry for not stopping it," the fraternity members said, according to ABC.
#according
2 months ago
On September 4, 2026, the Wall Street Journal reported that Starbucks Corporation (NASDAQ:SBUX)' longtime chai latte devotees have turned against the company's reformulated recipe, introduced in March. It reduced sweetener and shifted from a pre-made concentrate to a new base with just two grams of sugar.
Customers have signed petitions, flooded Starbucks' corporate lines, and taken to Reddit and store review sites demanding the original formula back. Starbucks says the change gives customers more control over sweetness and has introduced new variations like Mango Cream Chai and Pumpkin Cream Chai.
Starbucks Corporation (NASDAQ:SBUX)' broader turnaround remains intact despite the backlash over its chai reformulation. Global comparable sales increased 7.9% in fiscal Q3, with comparable transactions rising 4.2%. The company raised its fiscal 2026 adjusted EPS guidance to $2.55-$2.65 from $2.25-$2.45. Stronger customer traffic and higher earnings give investors evidence that one unpopular menu change has not derailed the recovery.
The chai backlash appears concentrated among loyal customers of one product rather than across Starbucks' broader customer base. The business introduced the new chai formula as part of a personalization strategy. Customers can customize sweetness and other ingredients. If Starbucks keeps transaction growth across its wider menu, the business could improve its product economics without materially damaging overall customer demand.
Starbucks is improving profitability while it executes its turnaround. Non-GAAP operating margin expanded 430 basis points year over year to 14.4% in fiscal Q3, while North America revenue increased 7% to $7.4 billion. These results give investors evidence that the company can improve margins and sales even as it experiments with its menu and customer experience.
#customer
Customers have signed petitions, flooded Starbucks' corporate lines, and taken to Reddit and store review sites demanding the original formula back. Starbucks says the change gives customers more control over sweetness and has introduced new variations like Mango Cream Chai and Pumpkin Cream Chai.
Starbucks Corporation (NASDAQ:SBUX)' broader turnaround remains intact despite the backlash over its chai reformulation. Global comparable sales increased 7.9% in fiscal Q3, with comparable transactions rising 4.2%. The company raised its fiscal 2026 adjusted EPS guidance to $2.55-$2.65 from $2.25-$2.45. Stronger customer traffic and higher earnings give investors evidence that one unpopular menu change has not derailed the recovery.
The chai backlash appears concentrated among loyal customers of one product rather than across Starbucks' broader customer base. The business introduced the new chai formula as part of a personalization strategy. Customers can customize sweetness and other ingredients. If Starbucks keeps transaction growth across its wider menu, the business could improve its product economics without materially damaging overall customer demand.
Starbucks is improving profitability while it executes its turnaround. Non-GAAP operating margin expanded 430 basis points year over year to 14.4% in fiscal Q3, while North America revenue increased 7% to $7.4 billion. These results give investors evidence that the company can improve margins and sales even as it experiments with its menu and customer experience.
#customer
2 months ago
RF Industries, Ltd. (NASDAQ:RFIL) reported stronger fiscal third-quarter results on September 14. Revenue increased 21% to $23.96 million for the quarter ended July 31, 2026, while operating income reached approximately $1.8 million, compared with $720,000 a year earlier.
The next question is whether new orders can sustain that performance. Quarterly bookings totaled $22.5 million, below revenue. Backlog stood at $18.6 million at quarter-end and increased to $19.8 million by September 14.
Bookings measure new orders, including modifications or cancellations of earlier orders. Backlog represents orders received for which revenue has yet to be recognized.
RF Industries, Ltd. (NASDAQ:RFIL) improved both sales and profitability. Gross margin increased to 35.6% from 34% a year earlier, helping operating income grow much faster than revenue.
Management attributes the margin expansion to a shift toward customized cabling and integrated systems. These offerings involve more engineering and larger projects than traditional component sales. Competing on technical capability and customer requirements could support stronger relationships and repeat business.
#earlier
The next question is whether new orders can sustain that performance. Quarterly bookings totaled $22.5 million, below revenue. Backlog stood at $18.6 million at quarter-end and increased to $19.8 million by September 14.
Bookings measure new orders, including modifications or cancellations of earlier orders. Backlog represents orders received for which revenue has yet to be recognized.
RF Industries, Ltd. (NASDAQ:RFIL) improved both sales and profitability. Gross margin increased to 35.6% from 34% a year earlier, helping operating income grow much faster than revenue.
Management attributes the margin expansion to a shift toward customized cabling and integrated systems. These offerings involve more engineering and larger projects than traditional component sales. Competing on technical capability and customer requirements could support stronger relationships and repeat business.
#earlier
2 months ago
No matter how well you plan for retirement, there are surprises that could throw you for a loop. The stock market might crash unexpectedly. Your healthcare costs might increase. Or, worse yet, you could end up needing long-term care at some point.
But one hiccup you should know to plan for is inflation. Over time, the cost of living is likely to rise. And if you aren't prepared, you could easily end up losing out on buying power. These two adjustments to your retirement plan could help you avoid that fate.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ******* ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
It's fairly common for retirees to reduce their stock holdings to minimize risk in their portfolios. But while it's OK to de-risk to some degree, you don't want to dump your stocks completely. Doing so could cause your portfolio to trail inflation, leading you to lose buying power and putting your savings at risk of being depleted.
If you're not comfortable holding individual stocks in retirement, buy shares of an S&P 500 exchange-traded fund (ETF). This effectively gives you exposure to the market. Or load up on dividend ETFs that generate steady income.
#plan #market
But one hiccup you should know to plan for is inflation. Over time, the cost of living is likely to rise. And if you aren't prepared, you could easily end up losing out on buying power. These two adjustments to your retirement plan could help you avoid that fate.
Missed AI's "Act 1"? Act 2 Could Be 15x Bigger. Most investors think they missed the AI boat because they didn't buy Nvidia in 2005. But according to our ******* ysts, we're only at the end of "Act 1"—the R&D phase. "Act 2" is the global rollout. Continue »
It's fairly common for retirees to reduce their stock holdings to minimize risk in their portfolios. But while it's OK to de-risk to some degree, you don't want to dump your stocks completely. Doing so could cause your portfolio to trail inflation, leading you to lose buying power and putting your savings at risk of being depleted.
If you're not comfortable holding individual stocks in retirement, buy shares of an S&P 500 exchange-traded fund (ETF). This effectively gives you exposure to the market. Or load up on dividend ETFs that generate steady income.
#plan #market
2 months ago
Elon Musk has never shied away from ambitious timelines, and his most recent one connects two companies directly together. In a post on X dated September 13, Musk stated that he is "highly confident" that **** e Exploration Technologies Corp. (NASDAQ:SPCX) will transport NVIDIA Corporation (NASDAQ:NVDA) Vera Rubin NVL72 AI computers into orbit next year, repeating a plan that has already moved both companies' stock this year.
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
The comment strengthens **** eX's Starmind concept, which aims to establish AI data centers in orbit rather than on the ground. The first satellite, named Starmind AI1, will carry a **** e-optimized version of NVIDIA's Vera Rubin NVL72 rack-scale system. The standard terrestrial NVL72 combines 72 Rubin GPUs and 36 Vera CPUs, although **** eX and NVIDIA have not disclosed the final configuration of the orbital version. **** e Exploration Technologies Corp. (NASDAQ:SPCX) plans to launch the satellite in the fourth quarter of 2027 and reach substantial scale by 2028. Musk's plan isn't new; during **** eX's first earnings conference as a public company in August, he stated that the company would build exclusively on NVIDIA hardware in the future, calling the Vera Rubin architecture the best available AI computer design.
Musk's central point is that **** e is, in the long run, the most cost-effective area to develop AI computing. He cites solar power availability in orbit as a crucial advantage, and estimates that within two to three years, **** e might become the lowest-cost place for AI computing in general, describing the orbital architecture as simpler, less expensive, denser, and lighter than a standard data-center rack. Not everyone believes the physics and economics will align on Musk's timeframe. Microsoft President Brad Smith has publicly questioned the broader concept, telling reporters that he would be surprised if companies actually transferred computation from land to low-Earth orbit.
For NVIDIA Corporation (NASDAQ:NVDA), the read-through is simple: **** e-based computing would represent a new, if early-stage and speculative, source of demand for its Vera Rubin platform, on top of the company's strong position in terrestrial AI infrastructure. According to some **** yst models, **** eX accounts for approximately 5% of NVIDIA's revenue.
SpaceX's reasoning is more convoluted. The plan is entirely dependent on the success of Starship, **** eX's next-generation rocket system, which still needs to demonstrate its capacity to handle launch frequency and reliability on the scale Musk describes. When Musk said during **** eX's August earnings call that the company would build its future AI infrastructure exclusively on NVIDIA, NVDA shares rose more than 4%, while **** eX's shares fell more than 10% before paring losses, reflecting investor concerns about execution risk and capital intensity, despite the fact that the NVIDIA relationship was well received.
#Companies
2 months ago
The price of jet fuel averaged $4.53 USD per gallon for the week ending Sept. 18, according to the latest Airlines for America U.S. Jet Fuel Index.
Driven by the war in Iran and closure of the Strait of Hormuz following the U.S.-Israeli strike on Iran at the end of February 2026, this price is a nearly 80% increase from the national average a year ago.
As a result, almost every major and regional airline has had to keep reworking its networks to maximize jet fuel use and ruthlessly cut any flights not bringing in the expected traffic.
Airline chief executives have also been sounding the alarm on what prolonged jet fuel prices could mean for the industry.
"If fuel prices remain as high as they are right now, I think that that's going to require some adjustments in terms of our capacity planning as we take a look into the future," American Airlines CEO Robert Isom said at the annual Morgan Stanley Laguna Conference in California on Sept. 16, Airline Geeks reported.
#airlines #price #index
Driven by the war in Iran and closure of the Strait of Hormuz following the U.S.-Israeli strike on Iran at the end of February 2026, this price is a nearly 80% increase from the national average a year ago.
As a result, almost every major and regional airline has had to keep reworking its networks to maximize jet fuel use and ruthlessly cut any flights not bringing in the expected traffic.
Airline chief executives have also been sounding the alarm on what prolonged jet fuel prices could mean for the industry.
"If fuel prices remain as high as they are right now, I think that that's going to require some adjustments in terms of our capacity planning as we take a look into the future," American Airlines CEO Robert Isom said at the annual Morgan Stanley Laguna Conference in California on Sept. 16, Airline Geeks reported.
#airlines #price #index
2 months ago
Some offers on this page are from advertisers who pay us, which may affect which products we write about, but not our recommendations. See our Advertiser Disclosure.
If you're thinking about how to maximize your savings, chances are you've come across high-yield savings accounts (HYSAs) and certificates of deposit (CDs). Both can offer competitive interest rates that drastically outpace those of traditional savings accounts. But which account — an HYSA or a CD — will earn you more in one year?
Here's a look at how the earnings on a $10,000 deposit compare over 12 months, based on the interest rate and account type.
On average, savings accounts currently earn just 0.38% APY. However, traditional savings accounts and HYSAs can offer vastly different yields.
For example, a savings account from Chase Bank earns 0.01% APY. Meanwhile, some of the best HYSAs earn above 4% APY.
#savings #hysas #account #deposit
If you're thinking about how to maximize your savings, chances are you've come across high-yield savings accounts (HYSAs) and certificates of deposit (CDs). Both can offer competitive interest rates that drastically outpace those of traditional savings accounts. But which account — an HYSA or a CD — will earn you more in one year?
Here's a look at how the earnings on a $10,000 deposit compare over 12 months, based on the interest rate and account type.
On average, savings accounts currently earn just 0.38% APY. However, traditional savings accounts and HYSAs can offer vastly different yields.
For example, a savings account from Chase Bank earns 0.01% APY. Meanwhile, some of the best HYSAs earn above 4% APY.
#savings #hysas #account #deposit
2 months ago
Elon Musk is getting serious about putting artificial intelligence (AI) into orbit. The ***** eX (SPCX) CEO is reportedly confident the company can launch Nvidia (NVDA) powered AI systems into ***** e in 2027. ***** eX and Nvidia are working on a ***** e-optimized version of Nvidia's Vera Rubin NVL72 platform, and Musk says the system should be lighter, denser, and cheaper than a traditional data-center rack. That matters because ***** eX is trying to turn orbital computing into a major business, while Nvidia could gain another market for its AI hardware.
The opportunity is much bigger than a headline. ***** eX could eventually sell computing capacity from satellites just as it sells broadband through Starlink. Meanwhile, Nvidia could supply the chips behind that infrastructure. Investors should still remember that this is an emerging business, and commercial scale is not expected immediately. Still, the plan gives both companies another way to capitalize on the AI spending boom.
Why It's Time to Load Up on Nvidia Stock
Mark Cuban Says He Was Dizzy for Months, So He Built a VR Fix That Does at Home 'Much Of What A 180k Machine' Does
Bank of America Just Declared a 'Generational Entry Point' in U.S. Bonds. Why Investors Should Be Backing Up the Truck on Treasuries Here.
#NVIDIA #SpaceX #much #still
The opportunity is much bigger than a headline. ***** eX could eventually sell computing capacity from satellites just as it sells broadband through Starlink. Meanwhile, Nvidia could supply the chips behind that infrastructure. Investors should still remember that this is an emerging business, and commercial scale is not expected immediately. Still, the plan gives both companies another way to capitalize on the AI spending boom.
Why It's Time to Load Up on Nvidia Stock
Mark Cuban Says He Was Dizzy for Months, So He Built a VR Fix That Does at Home 'Much Of What A 180k Machine' Does
Bank of America Just Declared a 'Generational Entry Point' in U.S. Bonds. Why Investors Should Be Backing Up the Truck on Treasuries Here.
#NVIDIA #SpaceX #much #still
2 months ago
Evommune, Inc. (NYSE:EVMN) announced on September 8 that EVO756 missed its primary endpoint in a randomized, double-blind, placebo-controlled Phase 2b trial involving 121 adults with moderate-to-severe atopic dermatitis. The primary measure was the percentage change from baseline in Eczema Area and Severity Index, or EASI, at week 12. No tested dose met the primary or secondary endpoints, and development in that indication will stop.
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
Evommune, Inc. (NYSE:EVMN) had already discontinued EVO756 for chronic spontaneous urticaria following a June trial failure. Development continues in migraine prevention. The setbacks place greater weight on EVO301, which has positive Phase 2a eczema data and a Phase 2b study planned for mid-2027.
Evommune, Inc. (NYSE:EVMN) has clinical evidence supporting its next eczema program. In February, the company reported that EVO301 met the primary endpoint in a randomized, double-blind, placebo-controlled Phase 2a trial involving 70 adults. Participants received two intravenous doses or placebo over a 12-week study.
Evommune, Inc. (NYSE:EVMN) reported a 55% EASI reduction with EVO301 versus 22% with placebo at week 12, a difference of 33 percentage points. The study met its prespecified Bayesian success criterion, and a separate conventional ****** ysis showed statistical significance at p
2 months ago
Spring, Texas-based Hewlett Packard Enterprise Company (HPE) develops intelligent solutions in the United States, the Americas, and internationally. The company has a market cap of $74.2 billion and operates in five segments: Server, Hybrid Cloud, Networking, Financial Services, and Corporate Investments and Other, and offers general-purpose servers, workload-optimized servers, and integrated systems, among others.
Companies with a market cap of $10 billion or more are typically called "large-cap stocks." HPE fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the communication equipment industry.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock
#packard
Companies with a market cap of $10 billion or more are typically called "large-cap stocks." HPE fits squarely into that category, with its market cap exceeding this threshold and reflecting its substantial size and influence in the communication equipment industry.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
The Case for Selling CrowdStrike Stock
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock
#packard
2 months ago
Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the "Multi Cap Equity Fund". The letter can be downloaded here. The Multi Cap Equity Fund's Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index's 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East tensions and easing oil flow. Investor focus shifted back to artificial intelligence, despite component shortages like processing chips affecting profits and valuations. Valuation-sensitive investors are selective within the AI sector, in contrast to valuation-agnostic indexes that adopt a more relaxed strategy. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#mettler #quarter
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#mettler #quarter
2 months ago
Software stocks, once left in the dust, have bounced back in recent months as high-flying chip stocks take a back seat.
"One of the things that was greatly overstated earlier this year was the death of software," Brian Mulberry, Zacks Investment Management chief market strategist, told Yahoo Finance on Tuesday.
"In order to engage with these AI tools … you need software to customize those tools for your business, " he said.
The iShares Expanded Tech-Software Sector ETF (IGV) is up 15% over the past three months and more than 40% higher from its April lows. Among individual movers, Microsoft (MSFT) and Palantir (PLTR) are both up 30%, while Salesforce (CRM) has risen more than 50% since mid-June.
In comparison, the iShares Semiconductor ETF (SOXX) is down 17% over the three-month period, according to Yahoo Finance's AlphaSpace chart.
#brian
"One of the things that was greatly overstated earlier this year was the death of software," Brian Mulberry, Zacks Investment Management chief market strategist, told Yahoo Finance on Tuesday.
"In order to engage with these AI tools … you need software to customize those tools for your business, " he said.
The iShares Expanded Tech-Software Sector ETF (IGV) is up 15% over the past three months and more than 40% higher from its April lows. Among individual movers, Microsoft (MSFT) and Palantir (PLTR) are both up 30%, while Salesforce (CRM) has risen more than 50% since mid-June.
In comparison, the iShares Semiconductor ETF (SOXX) is down 17% over the three-month period, according to Yahoo Finance's AlphaSpace chart.
#brian
2 months ago
International Flavors & Fragrances Inc. (IFF), headquartered in New York, produces and markets cosmetic active and natural health ingredients for use in various consumer products. Valued at $21.3 billion by market cap, the company flavors and fragrances are individual ingredients and compounds of a large number of ingredients that are blended, mixed, and reacted together to produce proprietary formulas.
Companies worth $10 billion or more are generally described as "large-cap stocks," and IFF perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the specialty chemicals industry. IFF is a preeminent player in global flavors and fragrances, with 35,000+ products spanning food, beverage, personal care, and health & wellness. Its scale, innovation focus, and alignment with natural, sustainable, and customized ingredient trends support a competitive edge, while operations in 60+ countries provide access to emerging markets and evolving consumer preferences.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock
How to Play GME Stock as GameStop CEO Ryan Cohen Buys $20.3 Million in Shares
#ingredients #markets #Health #products
Companies worth $10 billion or more are generally described as "large-cap stocks," and IFF perfectly fits that description, with its market cap exceeding this mark, underscoring its size, influence, and dominance within the specialty chemicals industry. IFF is a preeminent player in global flavors and fragrances, with 35,000+ products spanning food, beverage, personal care, and health & wellness. Its scale, innovation focus, and alignment with natural, sustainable, and customized ingredient trends support a competitive edge, while operations in 60+ countries provide access to emerging markets and evolving consumer preferences.
Billionaire Charlie Munger, Who Died at 99, Skipped Insurance on His Mansion Since He Could Just Write a Check to Rebuild — 'All Intelligent People Do It My Way'
Nvidia CEO Jensen Huang Just Dropped Huge News for This Cybersecurity Stock
How to Play GME Stock as GameStop CEO Ryan Cohen Buys $20.3 Million in Shares
#ingredients #markets #Health #products
2 months ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#vaccine #pfizer #NYSE
2 months ago
The artificial intelligence (AI) boom is entering a new phase, and this time, the battle is moving deeper into the data center. It is no longer simply about who can build the fastest AI accelerator. Hyperscalers are scrambling for more compute, faster connectivity, and better power efficiency as AI workloads continue to grow at a breakneck pace. That is opening the door for chipmakers that can deliver customized, energy-efficient solutions at scale.
Qualcomm (QCOM) wants a seat at that table. The company just landed a major multi-generational collaboration with Amazon (AMZN) to supply customized silicon, systems, and related technology for large-scale AI data centers, with a focus on inference. The partnership also extends into high-speed optical connectivity, an increasingly critical piece of the AI infrastructure puzzle.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#customized #hyperscalers #amzn
Qualcomm (QCOM) wants a seat at that table. The company just landed a major multi-generational collaboration with Amazon (AMZN) to supply customized silicon, systems, and related technology for large-scale AI data centers, with a focus on inference. The partnership also extends into high-speed optical connectivity, an increasingly critical piece of the AI infrastructure puzzle.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#customized #hyperscalers #amzn
2 months ago
With a market cap of $30.1 billion, Willis Towers Watson Public Limited Company (WTW) is a leading global advisory, broking, and solutions company, serving clients worldwide. Through its two segments: Health, Wealth & Career and Risk & Broking, the firm delivers services that help organizations manage risk, optimize benefits, and enhance performance.
Companies valued over $10 billion are generally described as "large-cap" stocks, and Willis Towers Watson fits right into that category. Headquartered in London, the United Kingdom, the company combines deep expertise, data-driven insights, and innovative solutions to support businesses of all sizes.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#towers #public
Companies valued over $10 billion are generally described as "large-cap" stocks, and Willis Towers Watson fits right into that category. Headquartered in London, the United Kingdom, the company combines deep expertise, data-driven insights, and innovative solutions to support businesses of all sizes.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#towers #public
2 months ago
Pfizer Inc. (NYSE:PFE) and Valneva SE (NASDAQ:VALN) reported on August 14 that the European Medicines Agency has validated the Marketing Authorization Application for PF-07307405, the companies' experimental Lyme disease vaccine candidate, and will now begin the official review.
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
For a vaccine candidate first proposed in a 2020 collaboration deal between Pfizer Inc. (NYSE:PFE) and French biotech Valneva SE (NASDAQ:VALN), this represents the formal transition from years of clinical development into European regulatory review.
The application is based on the Phase 3 VALOR trial, a placebo-controlled, randomized study of 9,437 participants aged five and older from high-incidence Lyme disease locations in US, Canada, and Europe. Participants got four doses on a phased schedule: one at months 0, 2, and 5-9, followed by a fourth dosage around a year later, shortly before the start of the next Lyme season. Topline data released in March 2026 demonstrated efficacy of over 70% in reducing confirmed Lyme disease cases, with the vaccine generally tolerated and no safety issues detected. However, the statistical picture was less clean than the headline efficacy suggests. The first prespecified **** ysis, which served as the primary endpoint, showed 73.2% efficacy but failed the trial's predefined statistical criterion because the lower bound of the 95% confidence interval was 15.8%, below the required 20%. A second prespecified **** ysis showed 74.8% efficacy and did meet that threshold.
Valneva SE (NASDAQ:VALN), the smallest of the two partners, views the vaccine as a clean competitive setup. According to the company, PF-07307405 is the most advanced Lyme disease vaccine candidate currently in clinical development, a rare spot in the vaccine industry where new entrants often face competition from existing treatments. Under the terms of the 2020 partnership and license agreement, Pfizer Inc. (NYSE:PFE) will have exclusive rights to produce and commercialize the vaccine if it is approved, while Valneva SE (NASDAQ:VALN) will benefit as a development partner.
The institutional stance is very different between the two companies, reflecting their very different sizes. Pfizer Inc. (NYSE:PFE) is still a strong name in the institutional **** e, with hedge fund ownership stable at 83 funds in the second quarter of 2026, the same as the first quarter, reflecting its position as a large, diversified pharmaceutical holding, rather than a name driven by a specific pipeline event. Valneva SE (NASDAQ:VALN), however, has little hedge fund exposure, with only 4 funds holding a position in the second quarter, up from 1 in the first quarter, reflecting the continued lack of visibility of the smaller partner among institutional investors.
#disease
2 months ago
Retiring at 62 and living off a 401(k) until 70 keeps a couple in the 12% tax bracket, with an effective federal rate near 8% on roughly $133,000 in annual withdrawals.
Delaying Social Security to 70 grows each spouse's benefit by 8% per year, producing roughly $6,200 combined monthly in guaranteed, inflation-adjusted income plus a maximized survivor benefit.
Medicare's two-year income lookback means couples must keep joint MAGI below $218,000 or face IRMAA surcharges that add over $160 per month in Part B premiums.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
A 62-year-old couple with $1.8 million in a traditional 401(k) and matching $3,100 monthly Social Security benefits available at full retirement age is looking at one of the most tax-efficient windows in the entire retirement code. The plan: retire now, live off the 401(k) for eight years, and switch to two delayed Social Security checks totaling roughly $6,200 a month at 70. It sounds aggressive. The math says it is close to optimal.
#security #year #benefit
Delaying Social Security to 70 grows each spouse's benefit by 8% per year, producing roughly $6,200 combined monthly in guaranteed, inflation-adjusted income plus a maximized survivor benefit.
Medicare's two-year income lookback means couples must keep joint MAGI below $218,000 or face IRMAA surcharges that add over $160 per month in Part B premiums.
Read More: Learn 7 secret wealth tips high net worth investors use that most investors miss (sponsor)
A 62-year-old couple with $1.8 million in a traditional 401(k) and matching $3,100 monthly Social Security benefits available at full retirement age is looking at one of the most tax-efficient windows in the entire retirement code. The plan: retire now, live off the 401(k) for eight years, and switch to two delayed Social Security checks totaling roughly $6,200 a month at 70. It sounds aggressive. The math says it is close to optimal.
#security #year #benefit
2 months ago
White House chief of staff Susie Wiles is "cancer free," she announced on X on Sept. 16, 2026. "Some personal news I'm grateful to share. After a medical appointment at the Mayo Clinic this week, my pathology results came back clear," she explained.
Wiles was diagnosed with early-stage breast cancer in March and told the New York Times that her prognosis was "strong." Wiles did not disclose at the time what treatment she would undergo, but said it would last several weeks — during which time she planned to continue working. Noting that one in eight American women develops breast cancer at some point in their lives, Wiles posted on X at the time: "Every day, these women continue to raise their families, go to work and serve their communities with strength and determination. I now join their ranks."
A breast cancer diagnosis is life-altering, but Wiles's comments highlighted the progress that's been made in recent years. Breast cancer is now detected at Stage 0 or 1 — before it has spread — in the majority of cases. Survival rates have risen dramatically, but "the treatments we use to treat early-stage breast cancer have become more tailored" and less disruptive to women's lives, Dr. Lynn Dengel, a University of Virginia surgical oncologist, told Yahoo in March.
"Because [Wiles] was taking care of her health [and getting screened], not only will her prognosis be better, but it will probably minimize what treatment she has to go through and will benefit her work-life and overall balance," Dengel said. She added that most of her patients are diagnosed early and can continue to work while undergoing breast cancer treatment, reducing the financial burden and overall disruption to their lives.
Wiles was diagnosed at age 68 — slightly older than the median age (62) when most women learn they have breast cancer. More than 380,000 American women are diagnosed with some form of breast cancer each year, according to the American Cancer Society (ACS).
Breast cancer remains the most common form of cancer among women in the U.S., except for skin cancers. And rates are rising. But there's good news: More women are surviving the disease. Treatments have also improved, becoming tolerable enough that many women still work, as Wiles intends to do. Here's what to know about the disease, why rates are rising and how women can reduce their risks.
#breast #diagnosed
Wiles was diagnosed with early-stage breast cancer in March and told the New York Times that her prognosis was "strong." Wiles did not disclose at the time what treatment she would undergo, but said it would last several weeks — during which time she planned to continue working. Noting that one in eight American women develops breast cancer at some point in their lives, Wiles posted on X at the time: "Every day, these women continue to raise their families, go to work and serve their communities with strength and determination. I now join their ranks."
A breast cancer diagnosis is life-altering, but Wiles's comments highlighted the progress that's been made in recent years. Breast cancer is now detected at Stage 0 or 1 — before it has spread — in the majority of cases. Survival rates have risen dramatically, but "the treatments we use to treat early-stage breast cancer have become more tailored" and less disruptive to women's lives, Dr. Lynn Dengel, a University of Virginia surgical oncologist, told Yahoo in March.
"Because [Wiles] was taking care of her health [and getting screened], not only will her prognosis be better, but it will probably minimize what treatment she has to go through and will benefit her work-life and overall balance," Dengel said. She added that most of her patients are diagnosed early and can continue to work while undergoing breast cancer treatment, reducing the financial burden and overall disruption to their lives.
Wiles was diagnosed at age 68 — slightly older than the median age (62) when most women learn they have breast cancer. More than 380,000 American women are diagnosed with some form of breast cancer each year, according to the American Cancer Society (ACS).
Breast cancer remains the most common form of cancer among women in the U.S., except for skin cancers. And rates are rising. But there's good news: More women are surviving the disease. Treatments have also improved, becoming tolerable enough that many women still work, as Wiles intends to do. Here's what to know about the disease, why rates are rising and how women can reduce their risks.
#breast #diagnosed
2 months ago
The artificial intelligence (AI) boom is entering a new phase, and this time, the battle is moving deeper into the data center. It is no longer simply about who can build the fastest AI accelerator. Hyperscalers are scrambling for more compute, faster connectivity, and better power efficiency as AI workloads continue to grow at a breakneck pace. That is opening the door for chipmakers that can deliver customized, energy-efficient solutions at scale.
Qualcomm (QCOM) wants a seat at that table. The company just landed a major multi-generational collaboration with Amazon (AMZN) to supply customized silicon, systems, and related technology for large-scale AI data centers, with a focus on inference. The partnership also extends into high-speed optical connectivity, an increasingly critical piece of the AI infrastructure puzzle.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#customized #amzn
Qualcomm (QCOM) wants a seat at that table. The company just landed a major multi-generational collaboration with Amazon (AMZN) to supply customized silicon, systems, and related technology for large-scale AI data centers, with a focus on inference. The partnership also extends into high-speed optical connectivity, an increasingly critical piece of the AI infrastructure puzzle.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#customized #amzn
2 months ago
With a market cap of $30.1 billion, Willis Towers Watson Public Limited Company (WTW) is a leading global advisory, broking, and solutions company, serving clients worldwide. Through its two segments: Health, Wealth & Career and Risk & Broking, the firm delivers services that help organizations manage risk, optimize benefits, and enhance performance.
Companies valued over $10 billion are generally described as "large-cap" stocks, and Willis Towers Watson fits right into that category. Headquartered in London, the United Kingdom, the company combines deep expertise, data-driven insights, and innovative solutions to support businesses of all sizes.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#risk
Companies valued over $10 billion are generally described as "large-cap" stocks, and Willis Towers Watson fits right into that category. Headquartered in London, the United Kingdom, the company combines deep expertise, data-driven insights, and innovative solutions to support businesses of all sizes.
Goldman Sachs Expects Fed Chair Kevin Warsh to Raise Rates This Week — But Not Because of Oil Prices.
Morgan Stanley Doubles Down on Apple Stock as New Offerings Become 'More Exciting'
The EV Bubble Has Burst. How to Play Rivian Stock Now.
#risk
2 months ago
Weitz Investment Management, an investment management firm, released its second-quarter Q2 2026 investor letter for the "Multi Cap Equity Fund". The letter can be downloaded here. The Multi Cap Equity Fund's Institutional Class returned 7.90% in Q2, underperforming the Bloomberg U.S. 3000 Index's 15.71% gain. Markets rose in the quarter on hopes of de-escalating Middle East tensions and easing oil flow. Investor focus shifted back to artificial intelligence, despite component shortages like processing chips affecting profits and valuations. Valuation-sensitive investors are selective within the AI sector, in contrast to valuation-agnostic indexes that adopt a more relaxed strategy. Additionally, reviewing the Fund's top five holdings could help identify its best picks for 2026.
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#Equity #fund #weitz
In its second-quarter 2026 investor letter, Weitz Multi Cap Equity Fund highlighted Mettler-Toledo International Inc. (NYSE:MTD). Mettler-Toledo International Inc. (NYSE:MTD) manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. On September 15, 2026, Mettler-Toledo International Inc. (NYSE:MTD) closed at $1,330.40 per share. Over the past month, Mettler-Toledo International Inc. (NYSE:MTD) declined 6.64%, and its shares gained 4.43% over the past 52 weeks. Mettler-Toledo International Inc. (NYSE:MTD) has a market capitalization of $26.66 billion.
Weitz Multi Cap Equity Fund stated the following regarding Mettler-Toledo International Inc. (NYSE:MTD) in its Q2 2026 investor letter:
"Less familiar to shareholders may be our new position in Mettler-Toledo International Inc. (NYSE:MTD), a global supplier of precision measurement instruments across laboratory, industrial and food retailing applications where accuracy, reliability and regulatory compliance are vital. Its highly specialized sales and service organization is a key competitive advantage, working collaboratively with customers to optimize their workflows and improve productivity, reinforcing long-term customer relationships. We have long admired Mettler's business and purchased a small position during a brief period of price dislocation during the quarter."
Mettler-Toledo International Inc. (NYSE:MTD) is not on our list of the 40 Most Popular Stocks Among Hedge Funds. According to our database, 48 hedge fund portfolios held Mettler-Toledo International Inc. (NYSE:MTD) at the end of the second quarter, down from 50 in the previous quarter. While we acknowledge the potential of Mettler-Toledo International Inc. (NYSE:MTD) as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
#Equity #fund #weitz
2 months ago
Starbucks Corporation (NASDAQ:SBUX) is betting $1 billion that leather armchairs, rugs, and bookshelves can turn a recovering coffee business into a more profitable one. The company plans to upgrade as many as 9,000 North American stores into warmer, more comfortable **** es designed to bring back customers who stopped treating Starbucks as a place to sit and stay. The strategy arrives as CEO Brian Niccol's turnaround gains traction, but investors still need to see whether higher traffic can translate into stronger margins.
Pixabay/Public Domain
The store upgrades are part of Niccol's broader "Back to Starbucks" strategy, which has already helped reverse a prolonged sales slump. Global comparable-store sales increased 7.9% in the latest quarter, with transactions up 4.2% and average ticket up 3.5%. U.S. comparable sales also rose 7.9%, indicating that the recovery is being driven by more than higher prices.
Starbucks Corporation (NASDAQ:SBUX) is spending roughly $150,000 per store on the new uplifts, far below the cost of previous renovations, and the work can generally be completed overnight without closing stores. The company expects about 1,500 upgrades to be finished by the end of September and ultimately wants to reach 8,000 to 9,000 company-operated North American locations.
That matters because Starbucks Corporation (NASDAQ:SBUX) has gradually become optimized for transactions rather than lingering. Mobile orders now account for roughly one-third of U.S. transactions, more than twice their share in 2019. The new design is therefore an attempt to restore the "third place" concept without abandoning the convenience that has become central to the business.
#corporation #NASDAQ #sales #transactions
Pixabay/Public Domain
The store upgrades are part of Niccol's broader "Back to Starbucks" strategy, which has already helped reverse a prolonged sales slump. Global comparable-store sales increased 7.9% in the latest quarter, with transactions up 4.2% and average ticket up 3.5%. U.S. comparable sales also rose 7.9%, indicating that the recovery is being driven by more than higher prices.
Starbucks Corporation (NASDAQ:SBUX) is spending roughly $150,000 per store on the new uplifts, far below the cost of previous renovations, and the work can generally be completed overnight without closing stores. The company expects about 1,500 upgrades to be finished by the end of September and ultimately wants to reach 8,000 to 9,000 company-operated North American locations.
That matters because Starbucks Corporation (NASDAQ:SBUX) has gradually become optimized for transactions rather than lingering. Mobile orders now account for roughly one-third of U.S. transactions, more than twice their share in 2019. The new design is therefore an attempt to restore the "third place" concept without abandoning the convenience that has become central to the business.
#corporation #NASDAQ #sales #transactions
2 months ago
One of the longest-tenured members of the Houston Astros leadership will be taking his talents to the East Coast to try out a new professional sport.
On Monday afternoon, the NHL's Pittsburgh Penguins announced the appointment of Marcel Braithwaite as the team's new President of Business Operations.
Braithwaite has been promoted to the new role after 14 years with the Houston Astros. He notably served as the Senior Vice President of Business Operations and was one of the initial hires under the Jim Crane-led baseball organization.
"It's an honor to join the Penguins at such an exciting time under new ownership," said Braithwaite. "I am grateful to the Astros and look forward to serving the employees, fans and city of Pittsburgh by bringing a winning culture to this franchise alongside Geoff, Kyle and the rest of this talented Front Office."
As a member of the Astros' Executive leadership team, Braithwaite guided the franchise through several ballpark renovations, security upgrades and naming rights negotiations, ensuring the business maximized revenue opportunities while providing a best-in-class fan experience.
#astros #braithwaite #houston
On Monday afternoon, the NHL's Pittsburgh Penguins announced the appointment of Marcel Braithwaite as the team's new President of Business Operations.
Braithwaite has been promoted to the new role after 14 years with the Houston Astros. He notably served as the Senior Vice President of Business Operations and was one of the initial hires under the Jim Crane-led baseball organization.
"It's an honor to join the Penguins at such an exciting time under new ownership," said Braithwaite. "I am grateful to the Astros and look forward to serving the employees, fans and city of Pittsburgh by bringing a winning culture to this franchise alongside Geoff, Kyle and the rest of this talented Front Office."
As a member of the Astros' Executive leadership team, Braithwaite guided the franchise through several ballpark renovations, security upgrades and naming rights negotiations, ensuring the business maximized revenue opportunities while providing a best-in-class fan experience.
#astros #braithwaite #houston
2 months ago
It was a nail biter, but the San Diego Padres came away from it with a seven-game win streak and back-to-back sweeps for the third time this season. It was a great game to cap off the sweep. Ethan Salas finally notched his first big-league hit with a triple in Oracle Park, Fernando Tatis Jr. went 3-for-4 with two RBI and Manny Machado launched his 27th home run of the season.
The Friars will now turn to the Colorado Rockies to round out their penultimate road trip of the 2026 season. It's a four-game set in the hitter-friendly environs of Coors Field. With the way the Padres have been swinging their bats lately (37 runs in their last six games; 6.2 runs per game), they should have no problem keeping the good vibes rolling.
Sugano has been surprisingly good in the hitter-friendly confines of Coors Field. That said, he's still pitched to a 5.30 ERA. But that number goes down to 4.96 at home compared to 5.64 away. It's an interesting split to have when Colorado is known for being a hitter's dream.
The righty has been particularly awful recently. In his last seven starts, Sugano has pitched to a 7.71 ERA across 35 innings pitched. In his last three starts, he's surrendered a whopping 14 runs (16.0 IP). If San Diego's recently potent lineup can take advantage of that, they would be well on their way to their eighth straight win.
Since joining the Padres, it's no secret that Mize has struggled. He's posted a dismal 6.34 ERA in his first seven games. Much of that is believed to be due to a groin injury that Mize has been pitching through. It was reported earlier this week that that injury was the reason many scouts decided against Mize, lowering his trade stock.
#game #runs #last #Colorado
The Friars will now turn to the Colorado Rockies to round out their penultimate road trip of the 2026 season. It's a four-game set in the hitter-friendly environs of Coors Field. With the way the Padres have been swinging their bats lately (37 runs in their last six games; 6.2 runs per game), they should have no problem keeping the good vibes rolling.
Sugano has been surprisingly good in the hitter-friendly confines of Coors Field. That said, he's still pitched to a 5.30 ERA. But that number goes down to 4.96 at home compared to 5.64 away. It's an interesting split to have when Colorado is known for being a hitter's dream.
The righty has been particularly awful recently. In his last seven starts, Sugano has pitched to a 7.71 ERA across 35 innings pitched. In his last three starts, he's surrendered a whopping 14 runs (16.0 IP). If San Diego's recently potent lineup can take advantage of that, they would be well on their way to their eighth straight win.
Since joining the Padres, it's no secret that Mize has struggled. He's posted a dismal 6.34 ERA in his first seven games. Much of that is believed to be due to a groin injury that Mize has been pitching through. It was reported earlier this week that that injury was the reason many scouts decided against Mize, lowering his trade stock.
#game #runs #last #Colorado
